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In this study, adenylate cyclase regulatory mutants
were isolated from HBlOl and CA8300 strains. The cva gene
fragment was used to transform several cva mutants, via
pBR322 plasmid. From these studies, a direct correlation
between the levels of intracellular cAMP, adenylate
cyclase and ^-galactosidase was found. The cloned cva
fragment restored the level of cAMP to above normal range
within these cva mutant strains subsequent to
transformation. Indole acetic acid (lAA) significantly
elevated the levels of adenylate cyclase and cAMP in cell
cultures. Growth studies indicated that lAA served as a
modulator of cva gene expression at the transcriptional
level. Gel retardation experiment suggested that lAA
appeared to bind to cva gene fragment. Glucose catabolite
repression studies suggested that lAA can substitute cAMP
in eliciting gene expression of the lac operon.
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The regulation by cyclic adenosine 3', 5' mono¬
phosphate (cAMP)-cAMP activator protein (CAP) is one of
the most understood of all the cellular control systems.
In bacteria, cAMP-cAMP activator protein controls a
variety of biological activities such as cell division,
synthesis of many proteins, replication of certain
plasmids and flagella formation (Botsford, 1981; Pastan
et al.. 1976; Peterkofsky, 1976; Rickenberg, 1974). The
above controls are as a result of changes in the
intracellular concentration of cAMP. Another well studied
CAMP - mediated regulatory system is catabolite
repression. Cyclic AMP plays a central role in
controlling the catabolic activity of both prokaryotic and
eukaryotic cells, but its effects are mediated by two very
different mechanisms in these two cell types. In
bacteria, all known effects of cAMP are mediated by CAP,
whereas in eukaryotes they are mediated by a cAMP-
dependent protein kinase. In both types of cells,
the role of these proteins is to sense the intracellular
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concentration of cAMP. In bacteria, cAMP levels have
been reported to vary primarily with the carbon substrate
on which the cells grow (Epstein ^ , 1975) . For
example, it is well known that cells growing on glucose
or its analogs contain particularly low levels of cAMP
while those growing on a poor carbon source contain very
high levels of cAMP. However, it is not clear how glucose
and all other carbon sources modulate the levels of cAMP
within the cell. When the intracellular levels of cAMP
increase, cAMP-CAP complex activates the expression of
a series of genes in bacteria; whereas in animal cells,
the cAMP-dependent protein kinase responds to this signal
by phosphorylating other enzymes or proteins, for example,
those responsible for the breakdown of glycogen. Among
the genes that are activated in bacteria in response to
an increase in cAMP are those that encode the enzymes for
the catabolism of lactose, arabinose, maltose and other
sugars. (Aiba ^ , 1983; Mowa ^ , 1981; Pastan ^
al.. 1976; Rickenberg, 1974). These genes can be fully
expressed only when the intracellular concentrations of
CAMP are high. Essential steps in the activation process
include the binding of cAMP to the CAP and the
interaction of this complex at the promoters of catabolite
sensitive genes. Glucose and its analogs lower
intracellular cAMP levels which in turn causes a reduction
3
in the expression of the set of genes positively regulated
by the cAMP-CAP complex and an increase in the expression
of the other set of genes that are negatively regulated
by the cAMP-CAP.
The physiological effects of cAMP production has
been well studied in a number of bacterial cells under
many different growth conditions (Botsford, 1981; Pastan
et al. . 1976; Peterkofsky, 1976; Rickenberg, 1974;
Ullmann 1983). The CAP, through which cAMP exerts its
effect in bacteria, has been purified to homogeneity
(Anderson ^ , 1971; Rigg et , 1971), crystallized
and studied by x-ray crystallography (Mckay ^ al. / 1981;
McKay ^ , 1982). The DNA sequences that the cAMP-
CAP complex binds to have been determined (Dickson ^ ,
1975; Greenfield ^ » 1978; Mowa ^ / 1981;
Taniguichi ^ aT. , 1979; Ullmann, 1983). Adenylate
cyclase, which produces cAMP in Escherichia coli. has been
purified to homogeneity from a 5-fold overproducing strain
(Yang ^ , 1983). The native enzyme has a molecular
weight of 95,000 daltons as determined by gel filtration
and has been shown to exist as a monomer. Mutants in both
cva (which encodes adenylate cyclase) and crp (which
encodes CAP) have been isolated by Alper et (1978),
Perlman ^ (1969) , and Schwartz ^ (1970) .
Mutations in cpd. which codes for cAMP phosphodiesterase.
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have also been found in Salmonella tvphimurium as reported
by Neilson ^ (1973) , and Alper et (1975) . The
ova mutant cannot grow on a wide variety of carbon
sources due to its inability to synthesize the
necessary enzymes required for the metabolism of various
poor carbon sources. However, cva mutations also result
in a large number of poorly understood metabolic
consequences (Ullmann ^ , 1983) which include: slow
growth, various respiratory chain defects, resistance to
certain mutagens, antibiotics, and phages, sensitivity to
high salt concentrations and streptomycin as well as
alterations in outer membrane protein composition, and in
regulation of flagella, pili and fimbriae (Broman ^ ,
1974; Dills ^ ^.,1977; Kumar, 1976; Vogler ^ al..
1987) . Because these changes are also seen in crp
mutants, they may be understood as resulting from altered
regulation of transcription, and all seem to affect
membrane functions.
In the midst of this system, many questions and
apparent anomalies remain. Our knowledge of the
regulation of intracellular cAMP levels is limited. Among
the various factors that affect the intracellular cAMP
level, the rate of cAMP synthesis seems to be of major
importance (Botsford, 1981; and Pastan ^ , 1976).
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To clarify the control of cAMP synthesis, it is necessary
to study the regulation of adenylate cyclase activity and
cva gene expression. The cva gene from E. coli and S.
tvphimurium has been cloned and partially characterized
as reported by Roy and Danchin (1981) , Roy and Hiziza
(1983), Aiba ^ (1983) and Wang ^ (1981). Aiba
(1985) demonstrated both in vitro and in vivo that the cva
gene of E. coli is transcribed from one major and two
minor promoters with the transcription from the major
promoter being negatively regulated by cAMP-CAP. The
cAMP-CAP complex binds to a site which overlaps
extensively with the RNA polymerase binding site as
reflected by DNase I footprinting studies. There is a
report that cAMP - CAP act as an anti-terminator (Ullmann
et al. . 1983) and studies on cAMP excretion have shown
that most of the cAMP made is excreted (Buettner ^ ,
1973; Fraser ^ , 1978). No explanation for this
seemingly waste of energy has yet been found. It has also
been found that crn strains overproduce and then excrete
CAMP at 32 times the rate found with wild-type strains
(Fraser ^ al., 1978).
The phenomenon of cAMP overproduction in crp strains
has led investigators to explore whether the cAMP
overproduction was a result of the overproduction of
6
adenylate cyclase (Botsford ^ , 1978; Joseph ^ al..
1982; Majerfeld et , 1981).
An early report of an in vivo aeration assay of cAMP
with cells grown in medium in the presence as well as in
the absence of a carbon source led to the conclusion that
the amount of adenylate cyclase varied depending upon the
carbon source and whether a functional CAP was present
(Botsford ^ , 1978). Majerfeld ^ (1981)
subsequently used both an in vivo and an in vitro assay
of CAMP production to show that crp strains appear to
overproduce cAMP by two to four times the rate seen in
isogenic crp* strains. This overproduction in cAMP was
shown by a mixing experiment not to be due to a soluble
functional activator of adenylate cyclase. These authors
concluded that whereas cva was repressed two-fold by cAMP,
CAMP regulation was primarily due to the level of
adenylate cyclase activity and not its production. If
this is true, it would be anticipated that adenylate
cyclase activities determined in bacteria grown on
different carbon sources, should show a correlation with
the corresponding cAMP levels. Several attempts have
been made to establish such a correlation. However,
adenylate cyclase activities determined in intact or
toluenized bacteria, in the absence or presence of
different carbon sources, failed to correlate with the
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intracellular concentration of cAMP (Ullmann ^ , 1983;
Botsford and Drexler 1978; Janecek ^ , 1979; Majerfeld
et al., 1981) . Therefore, it was concluded that the
carbon source-dependent modulation of cAMP levels is not
directly related to the regulation of adenylate cyclase
activity.
Previous data from this laboratory have indicated that
small metabolites such as indole acetic acid, indole,
imidazole acetic acid and cAMP affect the regulation of
acetohydroxy acid synthase activities in E. coli and
possibly that of cAMP production (Williams, 1986). In
addition, it has also been demonstrated that indole acetic
acid complements certain genes involved in host range of
Ti plasmids of Aarobacterium tumefaciens (Kao ^ ,
1982) . Based on these facts, the present study was
undertaken to further understand the regulation of
adenylate cyclase gene expression and cAMP production in
E. coli K-12 using the small metabolites mentioned.
CHAPTER II
REVIEW OF LITERATURE
The regulation of cAMP concentration in E. coli has
been the topic of many inquiries but remains poorly
understood. It is conceivable that the intracellular cAMP
concentration in E. coli can be regulated by three
mechanisms: (l) The excretion of cAMP; (2) the
degradation of cAMP by the enzyme cAMP phosphodiesterase;
and (3) the inhibition of adenylate cyclase activity by
varying the amount of cAMP in the cell (Botsford et ,
1978). Adenylate cyclase, which catalyzes the synthesis
of CAMP from ATP, is believed to be one of the most
important points of control for cAMP levels in numerous
organisms (Botsford ^ , 1978).
The intracellular level of cAMP in E. coli was also
observed to vary depending on carbon sources in culture
media (Buettner et , 1973; Wayne ^ al., 1974; Epstein
et al., 1975). For example, it is well known that cells
growing on glucose contain particularly low levels of
CAMP. However, the actual mechanism through which glucose
decreases the level of cAMP is not clear. Glucose,
8
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fructose, sorbitol, mannose and mannitol are transported
inside the cell as phosphorylated derivatives at the
expense of phosphoenolpyruvate (PEP). Active excretion
of CAMP into the growth medium has been observed in whole
cells as well as in isolated membrane vesicles (Saier et
al., 1975). It is believed that isolated vesicles take
up CAMP by faciliated diffusion. This belief is based on
the finding that sugars and other energy sources lower
intracellular concentrations of cAMP in strains of E. coli
and S. tvphimurium which are deficient in cAMP
phosphodiesterase (Saier ^ , 1975). This effect
requires the presence of the specific transport system
responsible for entry of that sugar into the cell and
depends on the intracellular catabolic enzymes.
Excretion of cAMP in vesicles is energy-dependent;
however, in whole cells, sugars have two primary effects
on CAMP metabolism: (1) They (metabolizable and non-
metabolizable sugars) inhibit net synthesis of cAMP while
promoting its degradation; and (2) they (metabolizable
sugars only) stimulate efflux of cAMP into the
extracellular fluid (Saier ^ , 1975) . These results
suggest that the extrusion of cAMP from bacterial cells
is energy-dependent and is driven by an energized membrane
state. It has been discovered that if cells are growing
in steady state conditions at a rate proportional to the
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rate of synthesis, cAMP is excreted (Epstein ^ al».
1975). Excretion of cAMP was also observed in washed
cells upon addition of a carbon source to the growth
medium (Pastan ^ al., 1976).
Cyclic AMP phosphodiesterase hydrolyzes cAMP to 5' AMP.
The specific activity of this enzyme in E. coli is not
affected by the growth medium (Botsford ^ / 1978).
The accumulation of cAMP in cultures of strains lacking
CAMP phosphodiesterase is much higher than in cultures of
strains which possess cAMP phosphodiesterase activity;
nonetheless, the intracellular concentrations of cAMP
appear to be comparable regardless of whether activity is
present or absent. From this observation, one may
question the significance of cAMP phosphodiesterase in E.
coli. However, no evidence has been presented that would
suggest that cAMP phosphodiesterase is responsible for the
fluctuations in intracellular cAMP levels measured when
bacteria are grown on different carbon sources.
Adenylate cyclase, which catalyzes the synthesis of
CAMP from ATP, is believed to be one of the most important
points of control for cAMP levels in numerous organisms
(Botsford ^ al. / 1978). The structure of bacterial
adenylate cyclase, unlike that of the cAMP activator
protein (CAP) or the catabolite gene activator (CGA), is
poorly understood. Some evidence suggests that the
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control of cAMP concentration is exerted by regulating the
activity of the adenylate cyclase protein (Joseph ^ ,
1982; Majerfeld ^ al., 1981).
The phenomenon of cAMP overproduction in cro strains
has led researchers to investigate whether the cAMP
overproduction is an effect due to the overproduction of
adenylate cyclase or to an increase in the activity of
pre-existing adenylate cyclase. Botsford ^ (1981)
reported an in vivo aeration assay of cAMP in which cells
were grown in media supplemented and unsupplemented with
a carbon source. They concluded that the amount of
adenylate cyclase fluctuates depending upon the carbon
source and whether a functional CAP was present.
Adenylate cyclase activities determined in intact or
toluenized bacteria, in the absence or presence of carbon
sources differing in their catabolite repression effect,
and/or protein synthesis, failed to correlate with the
intracellular concentration of cAMP (Ullmann ^ , 1983;
Botsford ^ ^., 1978; Janecek ^ al., 1979; Majerfeld ^
al. . 1981). Majerfeld ^ (1981) used an in vivo as
well as an in vitro assay of cAMP production to
demonstrate that crp strains seem to overproduce cAMP by
two to four times the rate observed in isogenic crp*
strains. This overproduction was shown not to be the
result of a soluble functional activator of adenylate
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cyclase. Since the cva gene was repressed by up to two¬
fold by CAMP, the authors concluded that cAMP regulation
was primarily at the level of adenylate cyclase activity
and not of adenylate cyclase production.
Bankaitis and Bassford (1982) presented evidences with
the isolation of cva-lac fusions in E. coli. that the
addition of 5 mM cAMP to minimal medium repressed cva gene
expression by two-fold. Nonetheless, because of their
observed maximum effect of only two-fold, they concluded
that repression of cva by the cAMP-CAP complex is not
physiologically significant.
Jovanovich (1985) recently reported the isolation of
cva-lac fusions in S. tvphimurium and examined the basic
physiology of the cva gene under a variety of growth
conditions. He found that in crp* and cro' backgrounds,
the cva gene has decreased expression when studied in a
complemented strain or under conditions known to increase
CAMP levels, or when cAMP is added externally. Using
higher cAMP concentrations (25 mM) than Bankaitis ^ al.
(1982), Jovanovich (1985) observed a nine-fold repression
of the cva gene, suggesting that the regulation might be
of physiological importance. One must note, however, that
25 mM is well above the level produced by wild-type cells
and although the results stated above support the theory
of repression of the cva gene by the cAMP-CAP complex, it
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does not exclude the possibility that CAP also negatively
regulates the activity of adenylate cyclase.
Adenylate cyclase, which is present in low amounts in
E. coli. has recently been purified to near homogeneity
and partially characterized (Yang ^ ^ / 1983).
These investigators purified adenylate cyclase 17,000-fold
(60% pure) from a 5-fold overproducing strain. The
molecular weight of the enzyme, as determined by gel
filtration, was found to be 95,000 daltons, and has been
shown to exist as a monomer. Additionally, Yang and
Epstein (1983) found the enzyme to be soluble, contray
to most other investigations (Tao ^ , 1970; Ide,
1971).
As mentioned earlier, the cAMP-CAP complex binds at
promoter sites to stimulate or inhibit the initiation of
transcription. However, the mechanism(s) by which cAMP
alters transcription is poorly understood. If one
examines the rate of cAMP synthesis in toluene - treated
cells (Harwood ^ , 1975) or in intact cells
(Peterkofsky ^ , 1975), it can be shown that sugars
that decrease the level of cAMP cause an instant
inhibition of cAMP synthesis. In addition, Aiba (1985)
demonstrated that the cva gene of E. coli is transcribed
from one major and two minor promoters, with the
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transcription from the major promoter being negatively
regulated by cAMP-CAP both in vitro and in vivo.
Moreover, he concluded that the cAMP-CAP complex serves
as a repressor for cva gene transcription. This
observation was based on DNase I footprinting studies
which indicate that the cAMP-CAP complex binds to a site
which overlaps extensively with the RNA polymerase binding
site. It has also been shown that the RNA polymerase-
promoter interaction is altered in the presence of cAMP-
CAP. It appears that cAMP-CAP inhibits cva gene
transcription by preventing the functional binding of RNA
polymerase to the promoter (Aiba, 1985), similar to the
mechanism of inhibition of lac transcription by the lac
repressor (Schmitz ^ , 1979).
The conclusions drawn from in vivo observations
strongly imply that the primary control of cAMP levels is
at the point of cAMP synthesis, the step catalyzed by
adenylate cyclase. When cells are totally disrupted,
regulation of adenylate cyclase is lost. The activity of
adenylate cyclase in cell -free extracts is low, sometimes
more than 10-fold below the high uninhibited levels seen
in vivo, and no effect of sugars that exert control in
vivo can be detected (Majerfeld ^ al., 1981; Tao ^ al..
1970).
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The regulation of adenylate cyclase activity by CAP
is well known, although the mechanism by which CAP
regulates adenylate cyclase expression or activity remains
unclear. Much evidence has been presented that would
suggest that some type of regulation occurs at the level
of transcription or translation of adenylate cyclase
itself or of one of its regulatory subunits (Ullmann ^
al.. 1983). Several investigators have drawn analogies
between the high level of cAMP production in CAP-deficient
cells and the transcriptional control of CAP on adenylate
cyclase expression (Fraser ^ , 1978; Rephaeli ^ al..
1976). Also, Botsford et (1978) and Majerfeld (1981)
have demonstrated that CAP-dependent regulation of
adenylate cyclase occurs directly at the level of gene
expression as well as indirectly at the level of enzyme
activity.
Ullmann and Danchin (1983) have examined the
correlation between cAMP levels and adenylate cyclase
activities in mutants lacking or over-producing CAP. They
reported that in CAP-deficient cells, the elevated levels
of CAMP production occur without a parallel increase of
adenylate cyclase activity; whereas, production of CAP
results in substantial inhibition of enzyme activity. One
may infer from this observation that CAP controls
primarily the activity rather than the synthesis of
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adenylate cyclase. Physiological analysis of in vitro
operon fusions between the cva control region and the lacZ
or tetR genes substantiates this hypothesis. Moreover,
no influence of cAMP has been observed on )0-galactosidase
or tetracycline expression (Roy ^ , 1982). Ullmann
and Danchin (1983) isolated a cva regulatory mutant of E.
coli. cva Rl, devoid of cyclase activity; this mutation,
croC. was located in the cm region (Guidi-Rontani et al..
1981). These results are more in accord with a complex
regulatory scheme encompassing, perhaps, an adenylate
cyclase regulatory (activating) subunit positively
controlled by CAP. On the other hand, CAP itself might
be a part of a regulatory complex directly influencing
cyclase activity as well as exerting a negative control
on cyclase expression (Guidi-Rontani ^ , 1981;
Majerfeld ^ , 1981).
The mechanism by which the internal concentration of
CAMP is regulated has not been elucidated. One
possibility is the modulation of adenylate cyclase
activity as a function of carbon source. A connection
between the phosphoenolpyruvate-dependent glucose
transport system (PTS) and adenylate cyclase activity has
been revealed (Peterkofsky, 1976). Enzyme I of the PTS,
a cytoplasmic protein, was thought to mediate the
controlling function of adenylate cyclase. However, it
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was discovered in temperature sensitive mutants in Enzyme
I, that temperature shifts did not affect adenylate
cyclase correspondingly. It was also demonstrated that
adenylate cyclase could be regulated in cells carrying a
deletion in the Enzyme I gene (Yang ^ , 1979).
Several investigations have suggested a close relationship
between PTS and adenylate cyclase. Therefore, a model was
proposed by Saier (1977) which introduced a link protein
which could be phosphorylated via Enzyme I and HPr (heat
stable protein). If a PTS substrate is available,
phosphate is preferentially transferred to the link
protein. In the phosphorylated state, the link protein
activates adenylate cyclase. The unphosphorylated control
protein would in turn inactivate adenylate cyclase.
A more reasonable explanation of how the transport
of energy substrates are coupled to control of the
adenylate cyclase was proposed by Gstrein-Reider and
Schweiger (1982). These investigators suggested that
there might exist a common arrangement of transport
systems surrounding the adenylate cyclase molecule. By
cooperativity of stringent coupling between the transport
systems, adenylate cyclase could be negatively controlled
by any one of the actively transporting energy uptake
systems. This direct regulatory coupling of energy
transport to adenylate cyclase indicates that production
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of CAMP does not reflect the energy situation of the
cells, but is a monitor of energy uptake. By directly
monitoring the energy uptake, the cell is able to react
promptly to alterations in the surrounding environment.
Thus, adenylate cyclase is presumably regulated by the
activity of transport systems for energy substrates
independent of whether or not the substrates can be
metabolized.
Wang ^ (1981) derived a cya gene clone from S.
tvphimurium DNA. Regions of the E. coli K-12 genome
containing the cva gene have also been subcloned and
analyzed (Roy et ^. , 1982; Aiba ^ , 1983; Koop ^
al. . 1984). In all of these investigations, it was found
that a cva gene truncated at the end corresponding to the
carboxy terminus of the protein was able to complement cva
deletion.
Roy ^ al. (1983) discovered that when the entire cva
gene is carried by a multicopy plasmid, there is a ten¬
fold overproduction of adenylate cyclase as compared to
the parental strain; however, no significant change in
sensitivity to glucose inhibition was reported. These
investigators further noted that truncated plasmids
lacking a COOH terminal fragment have adenylate cyclase
activity but no sensitivity to glucose inhibition. From
the final observation, the dramatic increases in cAMP
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levels in the stationary phase of growth occurred only
with the complete cva gene. Roy ^ (1983) concluded
that E. coli adenylate cyclase probably consists of two
functional domains; the amino-terminal, which features
catalytic activity and COOH-terminal, which is the target
of the phosphoenolpyruvate: sugar phosphotransferase-
mediated regulation.
The regulation of intracellular cAMP was also assessed
relative to the expression of catabolite sensitive operons
such as lac operon. The intracellular concentration of
CAMP is lower in E. coli cells grown in glucose, and
thereby, less /0-galactosidase is produced as compared to
cells grown on a carbon source such as succinate (Roy ^
al. . 1983). Koop ^ (1984) grew E. coli cells
containing plasmids with cva gene inserts on glucose or
succinate and assayed for ^S-galactosidase activity. It
was discovered that adenylate cyclase proteins made from
1.7 and 1.9 kb inserts appeared less efficient than the
wild type cva protein. Moreover, Koop's group found that
the synthesis of /3-galactosidase in cells possessing
truncated genes in multicopy plasmids to be rather
sensitive to glucose. These results, in contrast to the
findings of Roy ^ al. (1983) , suggest that the regulation
of the level of intracellular cAMP by glucose can occur
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in the absence of the carboxy terminus of adenylate
cyclase.
From this review of the literature, one can infer that
the mechanisms involved in the regulation of E. coli cva
gene expression as well as those controlling cAMP levels
are not well understood. Furthermore, the functions of
the cAMP-CAP complex in the expression of catabolite -
sensitive operons in E. coli cannot be reconciled with a
simple interpretation based on a positive control of
transcription initiation. The mechanisms by which the
internal concentration of cAMP is regulated remain in
question.
The purpose of the study was to further contribute
to our understanding of the mechanism(s) involved in the
regulation of the cva gene expression and those
controlling cAMP levels in E. coli by using small
metabolites.
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THE OBJECTIVES OF THIS STUDY
In order to characterize the modulation of cva gene
expression and cAMP levels in E^. coli by small
metabolites, the specific aims of the present study were
to;
1. Isolate and characterize adenylate cyclase (cya)
regulatory mutants;
2. Assess the molecular relationship between adenylate
cyclase activity and cAMP level;
3. Continue the anaylsis of the subclones of the cva
gene;
4. Develop an in vivo and/or an in vitro system to
precisely measure the effects of small metabolites
such as ppGpp, imidazole acetic acid, indole
acetic acid and cAMP upon the expression of the
adenylate cyclase structural gene cva;
5. Determine the adenylate protein patterns directed
by recombinant plasmids in the presence of certain
metabolites (as mentioned in #4);
6. Determine if any of the above metabolites that
affect the expression of the adenylate cyclase
structural gene cva were serving as a carbon source
or as a modulator;
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7. Determine whether the modulation was due to
transcriptional or translational mechanisms;
8. Determine if any of the above metabolites could
bind directly or via a receptor complex to the cya
gene fragment and therefore affect adenylate
cyclase gene expression and cAMP production;
9. Elucidate the possible mechanism(s) through which





Cyclic adenosine - 3', 5' - monophosphoric acid
detection kits and S] methionine were obtained from
Amersham Corp. Restriction enzymes were obtained from
Bethesda Research Laboratory (BRL), All other chemicals
were of reagent grade.
The minimal medium used was that of Davis and Mingioli
(1950), modified by omitting citrate and increasing the
glucose concentration to 0.5%. Glucose was aseptically
added to the medium after autoclaving separately at 10
Ib/in^ for 15 minutes. Tryptone broth contained 1.0%
tryptone, 0.5% NaCl, 0.12% MgSO^ and 12 mg thiamine per
liter. Luria broth (L-broth) contained 1.0% tryptone,
0.5% yeast extract, and 0.5% NaCl. Agar plates were
prepared by adding 1.5% agar to the medium before
autoclaving. Soft agar contained 0.6% agar.
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Organisms, Storage and Cultures
All strains of bacteria used in this study are
presented in Table 1. The strains originated from E. coli
K-12 stocks. Cell culture stocks were stored on nutrient
agar stabs wrapped in parafilm, and stored at 4° C. Batch
cultures were prepared from stocks by inoculating from
stabs into 5 ml tubes of tryptone broth or L-broth. Tubes
were incubated on a Gyrotory Water Bath shaker - Model G
76 at 37° C until stationary phase was attained. Lysates
were also prepared in L-broth.
Isolation of Adenylate Cvclase Gene (cva) Regulatory
Mutants
The combined methods of Kumar (1976) and Alper and
Ames (1978) were used to isolate adenylate cyclase (cya)
regulatory mutants. Cultures of CA8300 and HBlOl were
grown to approximately 2 x 10® cells per ml in tryptone
broth. Independent cultures from both CA8300 and HBlOl
were then infected with lambda - vir phage, and plated
directly on tryptone agar (TA) plates containing 5 ^g/ml
of streptomycin (Sm). After 64 to 72 hours of incubation
at 37°C, several colonies derived from each culture were
streaked onto Sm plates and incubated at 37°C. At least
one colony from one streak per culture was then tested for
lambda sensitivity by streaking against lambda-vir for
25




HB101 P“, hsdS20(rg~, ■b’)»




AW120 Cya* derivative of HB101
F“, hsdS20(rg”, Bg”),





CA8300 Hfr, SB®, thi-1 prototrryhic W. Heznikoff
AW118 Derivative of G18300,
Hfr, SB*, thi-1, eva*
eva* This study
CA83(l6 Hfr, Sta®, thi-1, cyt^ A£2. W. Reznikoff
CSR603 P~, thr-1, leuB6, prQA2,
phr-1, recA, argO, thi-1,
uvzA6, ara-14, lacfl, 9alK2,




PBR322 Ttet', Stock collection
pCyal Tet®, eva* This study
FCya2 ,^s . r ^ ♦ This study
FCya4 Tet®, Aop^, eva* This study
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ability to utilize lactose and maltose on minimal media.
Colonies that were lambda resistant, incapable of
fermenting lactose and maltose to the same extent as
wild-type and unable to swarm in semi- solid agar, were
isolated and further purified by streaking on TA medium.
Among the isolated clones, those that did not grow in
minimal glucose medium were not included in this
study. The remaining clones were repeatedly subjected to
tests for sensitivity to lambda, lactose and maltose
utilization, and motility in media supplemented and
unsupplemented with cAMP. The clones that behave like
parental strains, CA8300 and HBlOl, when provided with
CAMP were tentatively identified as cva mutants and the
others, not responding to supplemented cAMP, as cro'
mutants.
Biological Vectors Carrying the Cva Gene
This laboratory had previously cloned and subcloned
the cva gene into pBR322 plasmid via lambda transducing
phage (Figure 1) . Plasmid DNA was isolated from Ap'^TC®
cva* transformants by a combined procedure of Maniatis ^
al. (1982) and Rodriguez and Tait (1983) and used to
transform Ap®Tc® cva' strains. To verify that the plasmids
were carrying the cya gene, the transformants were grown
in minimal maltose and adenylate cyclase activity was
Fig. lA. Schematic representation of the cloning of
the cva gene of E. coli carried by phage



















Fig. IB. Schematic representation of the subcloning
of the cva gene of E. coli carried by phage
lambda CI857dilvC - cva.
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assayed. DNA samples from the recombinant plasmid carrying
cva gene (pCyal) were digested with restriction
endonuclease BamHl. and separated by 1.5% agarose gel
electrophoresis. The electrophoresis buffer was Tris -
HCl - acetate buffer at pH 8.0. Tracking dye consisted
of 30% glycerol in 0.25% bromophenol blue. Agarose gels
were stained with ethidium bromide (0.5 ug/ml). Each DNA
fragment was cut out from the gel, electro-eluded, and
extracted with an equal volume of phenol : chloroform :
isoamyl alcohol. The digested DNA plasmid was
precipitated with 2 volume of 95% ice-cold ethanol and 3
M NaAc and dissolved in TE buffer.
DNA from pBR322 was also digested with the
restriction endonuclease BamHl. Digested DNA was
extracted similarly to the above pCva* plasmid previously
described. The procedure of Moore and James (1978) was
used to ligate each separated fragment from oCval/BamHl
digest to BamHl digested vector pBR322. Covalent
joining of DNA fragments was verified by agarose gel
electrophoresis.
The recombinant plasmid carrying cva gene fragment
(pCya2), verified by assaying for adenylate cyclase
activity, was isolated, digested with BamHl and EcoRl
restriction endonucleases and separated by 1.5% agarose
gel electrophoresis. Each fragment was extracted from
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the gel by the procedure previously stated above, and
ligated into the BamHl - EcoRl site of pBR322. Each
recombinant plasmid was used to transform CA8306 bacterial
strain (a well characterized mutant carrying a full
deletion in the cva gene) and adenylate cyclase activity
was determined. The recombinant plasmid that conferred
adenylate cyclase activity to the mutant cell was
characterized as pCva4 and used for further
transformation.
Plasmid DNA Isolation and Purification
Plasmid DNA was isolated and purified according to the
methods of Birnboim ^ (1987) , Maniatis ^ (1982)
and Rodriguez and Tait (1983) . Cells were grown overnight
in 500 ml portion of L-broth containing 50 jug/ml
ampicillin. The following day, cells were pelleted in 500
ml bottle in JA - 10 rotor for 10 minutes at 5 K rpm. The
pellet was resuspended (by mixing and swirling) in 5 ml
of glucose - lysozyme solution (50 mM glucose, 25 mM Tris
- HCl, pH 7.5, 10 mM EDTA, and 20 mg/ml lysozyme dissolved
in deionized distilled water (dd H2O)) and allowed to sit
at room temperature for 5 minutes. Twenty ml of SDS -
NaOH solution (1% SDS and 0.2 M NaOH in dd H2O) were added
and the sample was placed on ice for 5 minutes. Fifteen
ml of potassium acetate solution (0.6 M potassium acetate
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and glacial acetic acid dissolved in dd H2O) were added,
and the contents were mixed by gently shaking before
incubating on ice for 15 minutes. The sample was
centrifuged at 8 K rpm for 10 minutes at 4°C, and the
supernatant was removed through gauze filters into clean
JA - 14 bottles. Fifty ml of phenol -chloroform -isoamyl
alcohol solution (25 parts of phenol, 24 parts of
chloroform and 1 part of isoamyl alcohol) were added (by
gently mixing and swirling), and the contents were
centrifuged at 6 K rpm for 5 minutes. The upper layer
(aqueous phase) was removed and transferred (via a pipet)
into another clean JA - 14 bottle. Plasmid DNA was
precipitated by adding 0.6 volume of isopropanol at room
temperature. The sample was allowed to sit at room
temperature for 1 hour. The pellet was collected by
centrifugation at room temperature in a JA - 14 rotor at
10 K rpm for 10 minutes. The pellet was dried in a vacuum
dryer for approximately 40 minutes and resuspended in 10
ml of TE buffer pH 7.5 (10 mM Tris - HCl, pH 7.5 and 1 mM
EDTA, pH 7.5). Ten grams of CsCl was added to the DNA -
TE mixture followed by 0.8 ml of EtBr. The contents were
then transferred to Ti - 65 ultra - centrifuge tubes using
a 20 ml syringe and the mixture centrifuged at 45 K rpm
at 15°C for 36 hours. After the centrifugation, the
plasmid band was extracted using a 5 ml syringe into 15
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ml plastic tubes. Ethidium bromide (EtBr) was removed by
three NaCl - saturated isopropanol extractions, and the
sample was dialyzed in TE buffer overnight in the cold
room (with replacement of fresh TE buffer after 45 minutes
and 2 hours) . The following day, the plasmid DNA was
transferred from the dialysis bag to a centrifuge tube
using a pipet, and precipitated with 1/10 volume 3 M NaAc,
pH 4.8, and 95% ETOH at -20°C for 2 hours. DNA was
pelleted at 10 K rpm for 20 minutes at -10°C and was twice
extracted with 70% ETOH and centrifuged each time at 5 K
rpm for 10 minutes at 4°C. The DNA pellet was dried in a
speed vac and resuspended in 100 ml of TE buffer.
Restriction Enzvme Digestion of Plasmid DNA
Isolated plasmid DNA was digested with
various restriction endonucleases as previously stated.
The reaction mixture contained 10 jul of plasmid DNA, 5 fil
of the appropriate buffer, 2 /il of the appropriate enzyme
and diluted to 50 lil using distilled water. The mixture
was incubated at 37°C overnight and then concentrated the
following day in a speed vac for 15 minutes.
Subsequently, the sample was subjected to agarose gel
electrophoresis (1.5%) in Tris - acetate buffer, pH 8.0,
(40 mM Trizma base, 20 mM NaAc and 2 itiM EDTA) containing
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0.5 ng/ml EtBr. The sample was visualized by UV
illumination following electrophoresis.
Recovering of Gene Fragment
Plasmid DNA containing the cva gene fragment (pCyal)
was digested with restriction enzyme BamHl and separated
on 1.5% agarose gel electrophoresis as stated above. The
three fragment bands (5.7 Kb, 4.4 Kb and 3.5 Kb)
generated from the above digest were cut out of the gel
and placed in individual dialysis bags containing 10 ml
of TE buffer and 1 jul of 10 mg/ml tRNA before
electrophoresis for 1 hour at 100 V. After 1 hour, the
electrodes were switched and electrophoresis was continued
for 1 minute to remove fragments that may have stuck to
the dialysis bag. Each fragment was transferred into a
10 ml centrifuge tube using sterile pasteur pipets,
and then precipitated overnight in 95% ETOH and 3 M
NaAc at -20°C. The following day, the DNA fragments were
pelleted through centrifugation at 10 K rpm for 10 minutes
at -10°C, and dried in a speed vac. Each fragment was
then resuspended in 10 /il of TE buffer and used in a
ligation reaction on a vector pBR322 previously digested
with BamHl. The ligation mixture contained 10 nl of 0.1
Ml/ml restriction fragment, 2 /ul of lOX T^ ligase buffer,
2 jul of 10 mM ATP, 20 units of T^ DNA ligase, and the
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reaction mixture was diluted to a volume of 20 Ml using
dd H2O. The mixture was incubated at 12°C for 24 hours.
At the end of incubation, 1 m1 of 0.5 M EDTA was added and
the samples were extracted once with phenol/chloroform.
The DNA samples were precipitated with 95% ETOH and 3 M
NaAc overnight at -20°C. The following day, the samples
were centrifuged at 10 K rpm for 10 minutes at -10°C,
dried in a speed vac and resuspended in 20 Ml of TE
buffer. Covalent joining of the DNA fragments were
verified by agarose gel electrophoresis. The DNA was then
used to transform competent cells of CA8306 (known to
carry a full deletion in the cva gene) , and adenylate
cyclase activity was assayed. Cells containing the
recombinant plasmid fpCva2) carrying the 3.5 Kb fragment
showed adenylate cyclase activity and hence, the 3.5 Kb
fragment was subjected further to a double digest using
restriction endonucleases BamHl and EcoRl. The digested
samples when analyzed on 1.5% agarose gels generated
2 fragments, 2.4 Kb, and 1.1 Kb. Each fragment was
recovered from the gel and ligated into the BamHl -
EcoRl site of pBR322 by the procedure previously stated
above. The recombinant plasmid that conferred adenylate
cyclase activity to bacterial strain CA8306 subsequent to
transformation was characterized as pCva4. This plasmid
was employed in subsequent transformation reactions.
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Transformation and Selection
Bacterial strains AW120 (adenylate cyclase regulatory
mutant isolated from HBlOl), AW118 (adenylate cyclase
regulatory mutant isolated from CA8300), and CA8306 (a
known adenylate cyclase mutant completely deleted in cva
gene) were transformed with pCva4. according to the
procedure of Cohen ^ (1972) . To verify that the
plasmids were carrying the cya gene fragment of E. coli,
adenylate cyclase activity was assessed in the above
transformants.
Bacterial strains listed above were grown to an OD of
0.85 at 550 nm in L-broth (5 g of tryptone, 2.5 g of yeast
extract, 2.5 g of NaCl and 0.5 g of glucose diluted to a
volume of 500 ml with dd HjO) . At this point, cells were
chilled on ice for 10 minutes, pelleted and washed in 0.5
volume of CaClj solution (50 mM CaClg and 10 mM Tris -
HCl, pH 8.0 dissolved in distilled water). Each cell
suspension was centrifuged at 8 K rpm for 5 minutes at
4°C. Following centrifugation, the cell pellet was
resuspended in 1/10 volume of CaCl2 solution, chilled on
ice for 15 minutes and pelleted at 8 K rpm for 5 minutes
at 4°C. The cells were resuspended in 1/15 volume of
CaCl2 solution. Two separate eppendorff tubes were set up
for each competent bacterial strain prepared from the
above as follows: Tube 1 contained 0.2 ml of competent
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cells treated with CaClg and 0.1 ml of diluted recombinant
DNA plasmid pCva; and tube 2 contained 0.2 ml of competent
cell treated with CaClj and 0.1 ml of diluted pBR322
plasmid. An additional incubation was done for 1 hour at
0°C. Bacteria were then subjected to a heat pulse at 42°C
by placing the reaction mixtures in a 42°C water bath for
2 minutes to enable uptake of plasmid DNA. Subsequently,
cells were inoculated into 1 ml of L-broth and incubated
for 1 hour at 37°C. Cells were then plated onto nutrient
agar plates containing 50 /xg/ml of ampicillin. Colonies
that grew on ampicillin plates were replica plated onto
plates containing 50 /xg/ml of ampicillin and 25 ng/ml of
tetracycline, and incubated overnight at 37°C. Ap*^ and Tc®
colonies were classified as cells carrying the recombinant
plasmid and then replica plated onto minimal glucose and
minimal maltose plates containing 50 ^g/vtxl of ampicillin.
Detection of Adenylate Cvclase and g-Galactosidase
Activities
Adenylate cyclase levels were indirectly assayed in
cva deficient mutants as well as in transformants by
measuring the levels of cAMP present in cell extracts.
Cell extracts were prepared by formic acid extraction as
reported by Cashel (1969) with slight modifications.
Cultures were grown to 2 x 10® cells per ml in minimal
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maltose medium supplemented with 0.1 mM proline and 0.1
mM casamino acids where appropriate. Five ml aliquots of
each culture were centrifuged at 8000 rpm in a Beckman
Model J-218 centrifuge for 10 minutes. One ml of TMG
buffer (1 ml MgSO^, 10 mM Tris and 1 ml 10 mg/ml gelatin
per liter) and 1 ml of 2 M formic acid were added to each
cell pellet. The cell suspensions were vortexed and
allowed to stand on ice for 45 minutes before centrifuging
at 8000 rpm. The supernatants were saved for cAMP assay.
Cyclic AMP levels were determined by a filter technique
encompassing a radioisotope dilution test with cyclic
adenosine 3', 5' - monosphosphoric acid. The method was
based on the competition between unlabelled cyclic AMP and
a fixed quantity of tritium-labelled cyclic AMP for
binding to a protein (i.e., CRP) which has a high affinity
for cyclic AMP. The amount of labelled cAMP - CRP complex
formed is inversely related to the amount of unlabelled
cAMP present in the assay sample.
The assay procedure was as follows: A number of
eppendorf tubes sufficient for the number of cell
extracts to be in duplicate and an additional 14 tubes for
standards and blanks were labeled and placed in ice. One
hundred and fifty (150) jul of Tris -EDTA buffer (0.05 M
Tris - HCl, pH 7.5, and 4 mM EDTA) was pipetted into assay
tubes 1 and 2 for the determination of the blank counts
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for the assay. Fifty (50) fil of Tris - EDTA buffer was
pipetted into assay tubes 3 and 4 for determination of
binding in the absence of unlabelled cyclic AMP. Fifty
(50) jul of 1.0, 2.0, 4.0, 8.0, 16.0 pmoles dilutions of
standard cAMP were added in pairs to assay tubes 5-14.
Fifty (50) /Ltl of each cell extract was added in duplicate
into the additional assay tubes. Fifty (50) /xl of the
labelled cyclic AMP was added to every assay tube.
Subsequently, 100 /il of the binding protein was added to
assay tubes 3-14 and to every assay tube containing the
cell extract. All tubes were mixed by vortexing for 5
seconds. The ice bath containing the tubes was placed in
a refrigerator at 2 - 4°C for 2 hours. Fifteen minutes
before the end of incubation, 20 ml of ice cold ddH20 was
added to a charcoal reagent (designed to remove unbounded
CAMP) and the container placed in an ice bath and stirred
continuously. The ice bath containing the assay tubes was
removed, and 100 ^1 of the charcoal suspension was added
to all tubes, vortexed for 10 -12 seconds and centrifuged
for 2 minutes at 12,000 rpm. Two hundred (200) ^il of the
supernatant from each tube was placed in a scintillation
vial and counted. Counts per minute (cpm) of the blank
was subtracted from the cpm of the zero standard as well
as from the 1, 2, 4, 8 and 16 pmol standards and samples
to give values designated Co and Cx, respectively. The
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Co/Cx values of the standards were plotted against the
corresponding pmol of the standard. The Co/Cx was
calculated for each sample and the cAMP content of the
sample was directly read from the calibration curve.
jS-galactosidase levels were measured in cya
deficient cells and transformants as reported by
Miller (1972) to determine if there was any correlation
between the levels of cAMP and )3-galactosidase.
Overnight cell cultures of the above cells were
prepared in L-broth. Each overnight culture was
subcultured into a fresh medium of the exact type used
above. Cultures were grown in 250 ml flasks placed in a
water bath shaker at 37°C until OD^qq of 0.70 was read on
a Bausch and Lomb Spectronic 20. Cultures were immediately
chilled in an ice bath to prevent further growth. One ml
aliquot of each culture was added to the assay medium (Z
buffer containing 0.06 M Na2HP04.7H20, 0.04 M NaH2P0^.7H2O,
0.01 M KCl, 0.001 M MgS0^.7H20 and 0.05 M B-mercapthanol)
to give a 1:10 dilution. To each ml of the assay mix,
0.02 ml of chloroform and 0.01 ml of 0.1% SDS solution
were added. The tubes were vortexed for 30 seconds and
the reactions incubated for 30 minutes and then terminated
with the addition of 5 ml of 1 M Na2C03 after yellow color
development. Optical densities of both 420 nm and 550 nm
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were recorded for each tube. The enzyme units were
multiplied by 1000 as defined by Miller (1972).
Assessment of the Effects of Small Metabolites on the
Expression of Adenylate Cvclase Structural Gene and cAMP
Production in Bacterial Strains
The effects of small metabolites on the production
of CAMP in: (1) Wild type cells, HBlOl, and CA8300; (2)
adenylate cyclase regulatory mutants AW120, AW118 and
CA8306; and (3) transformants AW120/pCya4, AW118/pCya4 and
CA8306/pCya4 were assessed. The levels of cAMP were
measured in cell extracts from the above cells grown under
minimal maltose in the presence and absence of 2 mM of the
following small metabolites: ppGpp, indole acetic acid,
imidazole acetic acid, indole and cAMP.
The Maxicell Protocol
To understand the effects of small metabolites on
the expression of adenylate cyclase structural gene, the
"Maxicell” protocol of Sancar ^ al. (1979) was used with
slight modification to examine plasmid-encoded proteins
of cya mutants cells carrying pCva4 recombinant plasmids.
Cells were grown in media supplemented and unsupplemented
with the above mentioned metabolites. SDS -
polyacrylamide gel electrophoresis analyses of protein
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lysates from the above cell extracts were performed.
Proteins were analyzed on vertical 5 - 10% polyacrylamide
gels.
Test of Ability of Small MeteJaolites to Serve as a Carbon
Source
The small metabolites that affected the expression
of cva gene and cAMP production were further assessed to
understand if they were serving as a carbon source or as
a modulator. Two mM of the small metabolites were added
as the sole carbon source to flasks containing minimal
media. Cells were grown in the media on a gyrotory water
bath shaker model G76 at 37° C, and growth monitored at
420 nm every hour for a period of twelve hours.
Assessment of Transcriptional and Translational Modulation
The small metabolites that affected the expression
of the cva gene expression and cAMP production were
further assessed to determine whether their effects were
due to a transcriptional or a translational mechanism.
Cells were grown in minimal media supplemented with
maltose for four hours. The level of adenylate cyclase
was indirectly assayed for by measuring cAMP levels
present in 1 ml cell extracts. Each cell culture was
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transferred into four flasks containing maltose minimal
media as follows:
Flask 1. Minimal medium containing maltose;
Flask 2. Minimal medium containing maltose and 2 mM of
indole acetic acid;
Flask 3. Minimal medium containing maltose and 1 mM of
rifampin ;
Flask 4. Minimal medium containing maltose, 2 mM of
indole acetic acid and 1 mM rifampin.
The cells were grown for 3 hours and the levels of
CAMP determined. In addition, cell extracts from aliquots
of cells grown in the above cultures were prepared for
protein products analysis by SDS - polyacrylamide gel
electrophoresis analysis.
Catabolite Repression Protocol
The small metabolites that affected the expression of
adenylate structural gene and cAMP production were further
assessed to determine if they could relieve glucose -
mediated catabolite repression. Relief of catabolite
repression by lAA or cAMP was determined as follows: One
ml culture of each cell was grown initially in 500 ml
lactose minimal medium supplemented with either 1 mM lAA
or imM CAMP. One ml duplicate samples were collected from
each culture when OD^qq reached 0.30 and /3-galactosidase
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levels determined. The remainder was divided into four
100 ml cultures supplemented with 0.4% lactose, 0.5% D-
glucose, and either lAA or cAMP (as in the initial
cultures) at 1, 2, 3 or 4 mM. One ml duplicate samples
were obtained from each culture after 2 hours and p-
galactosidase was assayed.
Binding of Small Metabolite(s) to Cva Gene Fragment
The binding of the small metabolites (that affect the
cya gene expression) to cva gene fragment was assessed
using a modified membrane binding technique (Ausubel ^
^.,1987). The modified membrane binding technique
involved incubating various concentrations of the small
metabolites (ranging from 0.05 mM to 4 mM) in the
presence and absence of 1 /il of cellular proteins in TKE
buffer (0.02 M Tris-HCl, pH 8.0, 0.6 M KCl and 0.001 M
NaEDTA) at 45®C for 10 minutes. Various concentrations of
DNA were added and the mixture (50 |il) incubated at 32°C
for 20 minutes. The samples were then chilled on ice for
10 minutes followed by chloroform - phenol extraction to
remove unbounded proteins. The aqueous phase was dialyzed
in TE buffer and precipitated with 95% ethanol. Samples
were then resuspended in the TE buffer, pH 7.5, and
analyzed by 1.5% agarose gel electrophoresis to see if
binding occurred (i.e., gel retardation analysis).
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Experimentation
All plate analyses, growth kinetic experiments
and catabolite repression experiments were performed
at least three times.
CHAPTER IV
EXPERIMENTAL RESULTS
Isolation of Adenylate Cvclase Gene (Cva) Regulatory
Mutants
Bacterial strains HBlOl and CA8300 were infected
with lambda - virulent phage before plating onto
enriched media supplemented with streptomycin to increase
the probability of isolating cm and cva mutants. Lambda-
resistant derivatives of the above wild type strains were
selected and subjected to tests for lactose and maltose
utilization in media supplemented with cAMP.
Strains HBlOl and CA8300 were selected as parental
lines because they are relatively easy to transform by
cloning vectors and both cya derivatives of HBlOl and
CA8300 served as proper hosts to test for complementation
by cva* plasmids. Mutants responding to various
concentrations of cAMP added to the growth media (Figure
2A and 2B) were identified as cva mutants. Others not
responding to varying cAMP levels were classified as cro
mutants.
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Fig. 2A. Growth patterns of strains HBlOl and AW120
(cya') in minimal media supplemented with
0.5% maltose, 0.05 M proline, and varying
concentrations of cAMP.
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Fig. 2B. Growth patterns of strains CA8300 and AW118
(cva') in minimal media supplemented with




Biological Vectors Carrying the Cva Gene
This laboratory had previously cloned and subcloned
the cva gene fragment onto pBR322 plasmid via lambda
transducing phage (Figure 1). The plasmid, fpCval), was
used to transform bacterial strain CA8306 because it has
a well characterized deletion in the cva gene. Therefore,
the cva prototrophy should be due to the integration
between the cloned cva fragment carried by the plasmid and
the chromosomal DNA of strain CA8306. The pCval plasmid
was isolated from CA8306 bacterial strain, analyzed by
0.8% agarose gel electrophoresis (Figure 3) before
digestion with restriction endonuclease BamHl. and
separation by 1.5% agarose gel electrophoresis, as
described in the experimental procedures. The BamHl
digest generated three fragments: 5.7 kb, 4.4 kb, and 3.5
kb fragments (Figure 4) . Each fragment was extracted from
the gel, ligated back into the BamHl site of pBR322. Each
recombinant plasmid generated was used to transform the
CA8306 strain, and cell extracts from the above were
prepared for adenylate cyclase assay as described in the
experimental procedures. Only the recombinant plasmids
carrying the 3.5 kb fragment showed adenylate cyclase
activity, indicating that the cva gene fragment resided
in the 3.5 kb fragment. The 3.5 kb fragment when digested
with BamHl and EcoRl restriction endonucleases generated
Fig. 3. Agarose gel electrophoresis of pCval. Small
aliquots of plasmid DNAs were run on a 0.8%
agarose slab gel containing ethidium bromide
(0.5 ug/ml).
Lane 1: pCval
Lane 2: Kb Ladder
Lane 3: pCval
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Fig. 4. Agarose gel electrophoresis analysis of pCval
digested with BamHl restriction endonuclease.
Small aliquots of plasmid DNAs were run on a
1.5% agarose slab gel containing ethidium
bromide (0.5 ug/ml).
Lane 1: 1 Kb ladder
Lane 2: pCval digested with BamHl restriction
enzyme




1.1 kb and 2.4 kb fragments. Only CA8306 cells carrying
recombinant plasmids with the 2.4 kb fragment showed
adenylate cyclase activity. The recombinant plasmids
were re - isolated from the CA8306 cells and a
combination of restriction enzymes BamHl and EcoRl was
used to recover the cva gene fragment (2.4 kb) cloned onto
the BamHl - EcoRl site of pBR322 (Figure 5) . The same
enzyme combination generated a fragment of about 0.4 kb
from wild-type pBR322 plasmid. The recombinant plasmid
carrying the 2.4 kb cva gene fragment fpCva4) was then
used to transform the following three cva' mutant: (1)
AW120; (2) AW118; and (3) CA8306 as described in the
experimental procedures. Strain AW120, a cva' mutant
isolated from strain HBlOl (recA') by previously described
procedures, was introduced in this round of
transformation. This is due to the fact that by using a
recA' strain, one can exclude the possibility that
complementation with the cva gene carried by the plasmid
resulted from recombination between the chromosomal DNA
and plasmid.
Detection of Adenylate Cvclase Activity
To further confirm that the cva gene had been
cloned, adenylate cyclase levels were indirectly assayed
in HBlOl, CA8300, their cva deficient mutants, as well as
Fig. 5. Agarose gel electrophoresis analysis of pBR322
and pCva4 digested with BaitiHl restriction
endonuclease. Small aliquots of plasmid DNAs
were run on a 1.5% agarose slab gel containing
ethidium bromide (0.5 ug/ml).
Lane 1; pBR322 digested with EcoRl and BamHl
Lane 2: pBR322




pCva4 digested with EcoRl and BamHl
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in transformants, by measuring the levels of cAMP present
in cell extracts. Cell cultures were grown to 2 x 10®
cells per ml in minimal - maltose media and 5 ml aliquots
of each were extracted using the formic acid extraction
procedure as previously stated. Cyclic AMP levels were
then measured by a radioisotope dilution techinque as
summarized in Table 2. This method was based on the
competition between unlabelled cyclic AMP and a fixed
quantity of tritium-labelled cyclic AMP for binding to a
protein (i.e., CRP) which has a high affinity for cyclic
AMP. The amount of labelled cAMP-CRP complex formed is
inversely related to the amount of unlabelled cAMP present
in the assay sample. A linear standard curve for cAMP
(Figure 6) was generated and used to determine the
concentrations of cAMP as outlined in Table 3. The
adenylate cyclase regulatory mutants, AW118 and AW120,
derived from CA8300 and HBlOl, respectively, showed low
levels of CAMP as compared with the wild-type strains.
The levels of cAMP in the mutant strains were not expected
to be zero since they possess point mutations in the cva
gene locus. When strains AW118 and AW120 were transformed
by the cva plasmid fpCva4) ,the level of cAMP was
substantially increased even beyond that of the
corresponding wild-types. The same cva mutants
transformed with pBR322 plasmid resulted in basically no
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Fig. 6. Linear calibration curve for determining
concentrations of cAMP in unknown samples.
Co/Cx values of standards (ordinate) were













0 cmole 7930.60 7747.80 1.25
1 rtnole 5099.00 4916.20 1.74 0m
2 cmole 3196.20 3013.40 2.23 _
4 cmole 2200.00 2017.20 3.21 . .
8 cmole 1823.60 1640.80 5.17
16 cmole 1044.40 861.60 9.09
Samples
HB101 1047.61 864.81 8.96 15.73 78.65
AMI 20 1783.59 1600.79 4.84 7.33 36.65
AW120/DCva4 615.16 432.36 17.92 34.02 170.10
CA8300 1432.45 1249.65 6.20 10.10 50.51
AW118 2989.97 2807.17 2.76 3.08 15.41
flW118/cCva4 980.92 800.72 9.68 17.20 86.02
CA8306 4267.04 4084.24 1.90 1.33 6.65
CM306/DCva4 780.56 597.76 12.96 23.90 119.50
Co ■ OM^^pStandatd - ®*blanlc
Qt ■ OMsiandapi • CEM blank xesp. ®*,anpLes”"^^*^lank
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4, Oetssnina'tlcn of B-Galactosidase Activity.









* 3-gaIactosidase assays and units viere as described in experiaental
protocol
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Assessment of the Effects of Small Metabolites on the
Expression of Adenylate Cvclase Structural Gene and cAMP
Production
The effects of small metabolites, such as, ppGpp,
indole acetic acid, imidazole acetic acid, indole, and
CAMP, upon the synthesis of cAMP were measured in cells
grown in minimal maltose media supplemented with 2 mM of
the above metabolites singularly at 37®C. Cyclic AMP
levels were measured and summarized in Table 5. The
rate of cAMP synthesis was significantly elevated in
cultures grown in the presence of indole acetic acid. A
slight increase in cAMP synthesis was noted in cell
cultures grown in the presence of indole with little or
no increase in cell cultures grown under imidazole acetic
acid and ppGpp supplementation. Cultures grown in the
presence of cAMP showed a slight decrease in cAMP
synthesis.
To understand the effects of the above small
metabolites on the expression of the adenylate cyclase
structural gene, the "Maxicell" procedure of Sancar ^ al.
(1979) was used to identify the plasmid-encoded proteins
of the cva recombinant plasmid in transformants. The
"Maxicell'• technique was used to incorporate [^^S]
methionine into plasmid-encoded proteins in the presence
and absence of small metabolites such as indole acetic
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TABLE 5. Effects of Metabolites (Indole Acetic Acid, Indole, Imidazole
Acetic Acid, Guanoaine 3', 5', —5, 3-TBtraphosphate and cAMP) on
cAMP Levels of Escherichia ooli K-12 Strains.
Saziples OM Co/Cx pool CAMP/
oer 200 ul
pool cAMP/ffll
BB101 1064.12 881.32 8.79 15.39 76.95
A»n20 1912.22 1729.42 4.48 6.59 32.96
AW120/pCya4 621.77 438.97 17.65 33.47 167.35
CA8300 1S04.95 1322.15 5.86 9.41 47.05
AW116 3174.23 2991.43 2.59 2.74 13.70
AWn8/pCie4 1008.79 825.99 9.38 16.59 82.96
CA8306 4303.97 4121.17 1.88 1.29 6.45
CA8306/pCya4 756.71 573.91 13.50 25.00 125.00
HB101 * lAA 529.92 347.12 22.32 43.00 215.00
AK120 lAA 1044.62 861.82 8.99 15.80 79.00
AW120/pCya4 + lAA 323.52 140.72 55.06 109.82 549.10
CA8300 * lAA 829.53 646.73 11.98 21.90 109.50
AW118 lAA 1625.59 1442.79 5.37 8.41 42.05
AWn8/pCya4 ♦ lAA 484.74 301.94 25.66 49.82 249.10
CA8306 f lAA 4197.20 4014.40 1.93 1.39 6.95
CA83C6/pCya4 + lAA 371.75 188.95 41.00 81.12 405.60
HBlOl + 1 639.36 456.56 16.97 32.08 160.40
AW120 ♦ I 1461.31 1278.51 6.06 9.82 49.10
AW120/pQ«4 + 1 450.80 268.00 28.91 56.45 282.25
CA8300 + 1 944.63 761.83 10.17 18.20 91.00
AM118 * I 1943.66 1760.86 4.40 6.43 32.15
AWn8/pCya4 ♦ I 695.90 513.10 15.10 28.27 141.35
CA8306 * 1 4197.20 4014.40 1.93 1.39 6.95
CA8306/pCya4 + I 550.17 367.37 21.09 40.49 202.45
HB101 * lA 1009.67 826.87 9.37 16.57 82.85
AW120 * lA 1729.27 1546.47 5.01 7.67 38.35
AW120/pCya4 lA 612.76 429.96 18.02 34.22 171.10
CA8300 * lA 1382.15 1199.35 6.46 10.63 53.15
AH118 * lA 2516.48 2333.68 3.32 4.22 21.10
Mni8/pCya4 4- lA 942.39 759.59 10.20 18.27 91.35
CA8306 4- ZA 4176.10 3993.30 1.94 1.41 7.05
CA8306/^pCya4 * lA 771.99 589.19 13.15 24.29 121.45
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‘D^LE S (OSNIINUED)
Sandies OM Co/iCx pCEOl CAMP/
oer 200 ul
pnsl cAMP/ml
HB101 ppQpp 1099.70 916.90 8.45 14.69 73.45
ASin20 ppG^ 1980.43 1797.63 4.31 6.24 31.25
AW120/pC^4 't' ep^ 6S8.13 457.33 16.30 30.71 153.55
Q18300 pp(^ 1408.72 1225.92 6.32 10.35 51.75
AW118 3162.72 1979.92 2.60 2.76 13.80
AW118/pC^4 + ppC^jp 10S0.42 867.62 8.93 15.67 78.35
CA83Q6 4282.17 4099.37 1.89 1.31 6.55
CM306/pCya4 + ppC^ 877.67 694.87 11.15 20.20 101.00
HB101 CAMP 116a.S3 98S.73 7.86 13.49 67.45
AW120 + CAMP 20S4.25 1871.45 4.14 5.90 •29.50
AW120/pCya4 -t- cAMP 743.02 560.22 13.83 25.67 128.35
CA8300 + CAMP 1678.SI 1495.71 5.18 8.02 40.10
AW118 + CAMP 3641.64 3458.85 2.24 2.02 10.10
AWn8/pCya4 + cAMP 1098.62 915.82 8.24 14.71 73.55
CAS306 4393.56 4210.76 1.84 1.20 6.02
CA8306/pCya4 + cAMP 959.13 776.33 9.98 17.82 89.10
CAMP » Cyclic adftnosina 3', S' • acnophosohats
I s Indole
a Imidazole eioetic add
lAA s Indole acetic add
ppGpp » Guanosine 3', S' - S', 3 - tetraphosgfaate
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acid, imidazole acetic acid, cyclic AMP, ppGpp and indole.
The "Maxicell" technique allows the preferential
incorporation of amino acids into proteins encoded by DNA
of multicopy plasmids with minimal background
incorporation resulting from the host cell's chromosome.
Data from autoradiograms of SDS - polyacrylamide
gel electrophoresis of "Maxicells" harboring plasmids
containing the cva gene indicated that the cya
derivatives of plasmid pBR322 were substantially different
from the parental plasmid pBR322. This is in accord
with the differences observed between the DNA forms of
plasmid pBR322 and the cva containing plasmids shown in
Figure 5. The cya plasmid (pCva4) gave rise to one major
protein not present in pBR322 containing cells (Figure 7) .
This protein had an apparent M,. of 95,000 and co-migrated
with partially purified adenylate cyclase. In addition,
several other bands were observed in the pCya4 containing
strains. Among the metabolites that were tested, it
appeared that indole acetic acid greatly increased the
amount of the 95 KDa protein. A slight increase of the
protein was noted in cells grown in the presence of
indole; however, little or no increase in cells grown
under imidazole acetic acid and a slight decrease in cells
grown under ppGpp and cAMP was noted.
Fig. 7. Autoradiogram of SDS - polyacrylamide gel
electrophoresis of cell lysates from the
"Maxicell" protocol. Proteins were labelled
by methionine, the growth media was
supplemented and unsupplemented with 2 mM of
certain small metabolites. Proteins were
analyzed on a vertical 5 - 7.5% polyacrylamide
gel. The gel was stained in 45% methanol,
0.25% coomassie blue and 9% acetic acid. After
destaining in 5% methanol and 7.5% acetic acid,
the gel was dried and subjected to
autoradiography for 2-3 days at -70°C.
Protein lysates are:
Lane 1: AW120/pCya4 + indole acetic acid
Lane 2: AW120/pCya4 + imidazole acetic acid
Lane 3: AW120/pCya4 + guanosine 3', 5' - 5*,
3' tetraphosphate
Lane 4: AW120/pCya4 + cyclic AMP
Lane 5: AW120/pBR322
Lane 6: AW120/pCya4
Lane 7: AW120/pCya4 + indole.
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In our laboratory, Baylor and Williams (unpublished
data) have previously employed the cloned cya gene
fragment in an in vitro transcription-translation system
in the presence and absence of certain metabolites. It
was found that the adenylate cyclase-catalyzed product
(cAMP) did not alter the amount of in vitro transcription
of the cva gene fragment; PEP and imidazole acetic acid
produced very little effect. The presence of ppGpp,
however, resulted in a strong inhibitory effect. Indole
acetic acid elicited a strong stimulatory effect upon in
vitro transcription. The above in vitro observations
paralleled the current observed in vivo results, except
for ppGpp and cAMP which only produced a slight inhibitory
effect in vivo.
Test of Ability of Small Metabolites to Serve as a Carbon
Source
From the results of the above experiments, indole
acetic acid greatly affected the expression of the
adenylate cyclase structural gene cya and was further
assessed to understand if it was serving as a carbon
source or as as modulator. Indole acetic acid was added
as the carbon source to cell cultures in minimal base
media at 37°C and growth was monitored at 420 nm every
hour for a period of 12 hours. The inability of indole
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acetic acid to serve as a carbon source was demonstrated
by the fact that cell cultures were unable to grow on
minimal media supplemented with indole acetic acid (Figure
8, A and B) . The same group of cells grew in glucose
minimal media indicating that the cells used were viable.
The fact that indole acetic acid did not serve as a carbon
source, but greatly increased the expression of adenylate
cyclase gene and cAMP production strongly suggested that
it must be serving as a modulator.
Assessment of Transcriptional and Translational Mechanisms
Indole acetic acid, which appeared to serve as a
modulator, was further assessed to determine whether its
effect was due to a transcriptional or translational
mechanism. Cells were grown in minimal media supplemented
with maltose for four hours. This step was necessary to
allow reasonable amounts of adenylate cyclase to be
synthesized before indole acetic acid (a modulator) and/or
rifampin (an inhibitor of transcription) was added. The
level of CAMP was measured and recorded in Table 6. Each
cell culture was then transferred into four flasks
containing maltose minimal media in the presence and
absence of indole acetic acid and/or rifampin. Rifampin
was utilized in this procedure in order to determine
whether the increase in the accumulation of cAMP in cell
Fig. 8A. Growth patterns of strains HBlOl, AW120, and
AW120/pCya4 in minimal media supplemented and
unsupplemented with indole acetic acid or 0.5%
glucose at 37°C.
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Time I Hours 1
Fig. 8B. Growth patterns of strains CAS300, AW118, and
AW118/pCya4 in minimal media supplemented and




TABI£ 6. Effects of Indole Asetic Acid on cAMP Levels in the Presence and
Absence of Rifanpin in Escherichia ooli K-12 Bacterial Strains.
Sanples OM CSM^-OW^ Co/Ol pml CAMP/
cec 200 ul
pool cAMP/U
BB1Q1 1699.00 1516.20 5.11 7.87 39.34
AW120 2674.05 2491.25 3.11 3.80 19.02
Atn20/pCya4 915.11 732.31 10.58 19.03 95.15
0^300 22.1634 2033.54 3.81 5.23 26.15
A»ni8 3688.59 3505.79 2.21 1.95 9.76
Aim8/pc^4 1474.10 1291.30 6.00 9.70 48.51
CA8306 4391.41 4208.61 1.84 1.21 6.03
CAa306/pCya4 1123.07 940.27 8.24 14.27 71.33
Levels of CAMP after splitting each cell culture into four flasks and cell grows
in the cresence or absence of indole acetic acid and/or Rifanpin for additional
3 hours
Samples OM CPM -CPMjj Co/Cx pool CAMP/ pDol cAMP/ml
oer 200 ul
BB101 1093.23 910.43 8.51 14.81 74.05
HBlOl + lAA 578.30 395.50 19.59 37.43 187.13
HB101 + RIF 1710.97 1528.17 5.07 7.97 38.95
HB101 + lAA + RIP 1748.01 1562.21 4.95 7.56 37.78
AW120 2027.51 1844.71 4.20 6.02 30.11
AW120 + lAA 1121.93 939.13 8.25 14.29 71.45
AW120 + RIF 2756.82 2574.02 3.01 3.59 17.95
ASn20 + lAA + RIP 2714.76 2531.96 3.06 3.69 18.43
AWl20/pCya4 629.62 446.82 17.34 32.84 164.21
AW120/pCya4 + lAA 376.11 193.31 10.08 79.23 369.17
AW120/pCya4 + RIF 924.22 741.42 10.45 18.78 93.88
AW120/pC^4 f lAA + RIP 923.51 740.71 10.46 18.80 94.01
CA8300 1532.59 1349.79 5.74 9.17 45.85
CAa300 lAA 894'.91 712.11 10.88 19.66 98.30
0^8300 RIF 2248.88 2066.08 3.75 5.10 25.50
ZA8300 lAA RIF 2221.70 2038.90 3.80 5.20 26.00
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TABLE 6 (CONTINUED)
Sandies CM CM^-CM^ Co/Cr pool CAMP/
per 200 ul
pnol cAMP/ml
AWlia 3117.52 2934.77 2.64 2.83 14.00
AW118 * lAA 1717.02 1534.22 5.05 7.76 38.55
AWnS RIP 3753.22 3570.42 2.17 1.88 9.42
AWlia + lAA ♦ RIF 3837.42 3654.62 2.12 1.78 8.89
Awn8/pcya4 1008.79 825.99 9.38 16.60 83.01
AWna/pCya4 + lAA 551.92 369.12 20.99 40.28 201.38
»ni8/pC^4 ♦ RIF 1507.21 1324.41 5.85 9.38 46.89
»fn8/pcya4 + lAA ♦ RIF 1502.70 1319.90 5.87 9.42 47.10
CA8306 4389.17 4206.37 1.84 1.21 6.04
CA8306 + lAA 4370.80 4188.00 1.85 1.23 6.13
CAS306 + RIF 4393.56 4210.76 1.84 1.21 6.05
CA8306 + lAA + RIF 4416.57 4233.77 1.83 1.20 6.00
CA8306/pCya4 772.88 590.08 13.13 24.25 121.24
CA8306/pCya4 lAA 443.67 260.87 29.70 58.07 290.35
CA8306/pCya4 RIF 1140.50 957.70 8.09 13.95 67.77
CA8306/pCya4 + lAA + RIF 1132.29 949.49 8.16 14.09 70.49
lAA > Indole acetic add
RIF Rifaocin
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cultures under indole acetic acid supplementation was due
to increasing new synthesis of adenylate cyclase or
activation of previously synthesized adenylate cyclase.
Analysis of the SDS-polyacrylamide gel electrophoresis of
the above cell extracts was performed (Figure 9) to
further examine the effects of the above treatments on the
synthesis of adenylate cyclase.
The data shown in Table 6 and Figure 9 indicated that
indole acetic acid was able to induce an apparent
increased synthesis of adenylate cyclase and cAMP in cell
cultures grown in minimal maltose media. The level of
CAMP was also noted to be directly correlated with the
accumulation of adenylate cyclase. However, when rifampin
was added, no further accumulation of adenylate cyclase
and cyclic AMP was observed even under indole acetic acid
supplementation. The above data, taken together,
indicated that the effects of indole acetic acid upon
adenylate cyclase and cAMP production was at the
transcriptional level.
Catabolite Repression of Lactose Qperon bv Glucose in cAMP
or lAA - Induced Cells
When D-glucose was added to cell cultures growing in
minimal lactose in the presence of 1 mM cAMP, it was
observed that the cAMP - mediated induction of the lac
Fig. 9. SDS - polyacrylamide gel electrophoresis of
protein lysates from transcriptional and
translational modulation experiments.
Proteins were analyzed on vertical 5-10%
polyacrylamide gels. Molecular weight
standards used were; (lane 1) Myosin (200.0Kda) ,
j8-galactosidase (116.10 Kda) , phosphorylase B
(97.4 Kda) bovine serum albumin (68.0 Kda), and
ovalbumin (43.0 Kda). Protein lysates are: (2)
HBlOl + minimal (mm) maltose grown for 4 hrs;
(3) HBlOl + mm maltose grown for 7 hrs; (4)
HBlOl + mm maltose grown for 7 hrs + indole
acetic acid added after 4 hrs; (5) HBlOl + mm
maltose grown for 7 hrs + rifampin added after
4 hrs; (6) HBlOl + mm maltose grown for 7 hrs
+ rifampin + indole acetic acid added after 4
hrs.







operon /9>galactosldase was catabolite repressed (Table 7).
Similar effects were seen when glucose was added to cell
cultures growing on lactose minimal media supplemented
with 1 mM lAA.
Because cAMP, at an elevated concentrations, had been
observed to reverse catabolite repression of a culture
growing in glucose (Pastan el^ al*» 1970),the ability of
increased concentration of lAA to reverse catabolite
repression was examined. When 2, 3, and 4 mM of lAA was
present during glucose addition to growing lAA - induced
cultures, there was an apparent decrease in the catabolite
repression response (i.e., /9-galactosidase). This was
also the case with cAMP (Table 7).
Binding of Small Metabolites to Gva Gene Pracment
The binding of indole acetic acid to cva gene fragment
was assessed using the modified membrane binding technique
previously described in the experimental procedures.
Various concentrations of the 2.4 kb cva gene fragments
and various concentrations of lAA ranging from 0.05 mM to
4 mM lAA were employed in the presence and absence of
cellular proteins to determine what concentrations would
be suitable for binding experiments. A concentration of
4 jug of cva gene fragments and 2 mM of lAA was established
as a suitable ratio. At^ this point, 2.0 jug of the 2.4 kb
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TABLE 7. Relief of Catabolite R^ression with cAMP or Indole
Acetic Acid (lAA).




HB101 glucose * lactose
HB101 + glucose + lactose
HB101 + glucose + lactose
HB101 + glucose + lactose
AW120 + lactose
AW120 + glucose + lactose
AW120 + glucose + lactose
AW120 + glucose + lactose
AW120 + glucose + lactose
CAS300 + lactose
CAS300 + glucose + lactose
CAS 300 + glucose lactose
CAS300 glucose lactose
CAS300 + glucose + lactose
AW118 ^ lactose
AW118 + glucose + lactose
AW118 glucose + lactose
AW118 + glucose + lactose





















*B-Galactosidase assays and units were as described in experimental protocol
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cva gene fragment was available for binding. The 2.4 /xg
of the 2.4 kb cva gene fragment and the previously
isolated 3.5 kb cya gene fragment were utilized in the
binding experiment both in the presence and absence of
cellular proteins. Samples were analyzed by 1.5% agarose
gel electrophoresis.
Data from the gel retardation experiment (Figure 10)
indicated that indole acetic acid could bind directly to
the 3.5 kb cva gene fragment even in the absence of
cellular proteins. There were no visible lanes containing
the 2.4 kb fragments. The reason for this could be due
to the low concentration of the 2.4 kb fragment available
for binding. This reason was suggested because in the
previous experimental trial, a concentration of 4.0 fig of
the 2.4 Kb cva gene fragment and 2.0 mM of lAA was
established to be a suitable ratio for the binding
procedure.
Fig. 10. Agarose gel electrophoresis analysis of cya
gene fragments employed in the binding
experiments in the presence and absence of 2
mM indole acetic acid and/or 1 ul of cellular
protein extracts.
Lane 1: pBR322 + 2 mM lAA
Lane 2: PBR322 + cell extract (binding mixture
extracted with phenol)
Lane 3: pBR322 + cell extract
Lane 4: 3.5 Kb cva gene fragment -f 2 mM lAA
Lane 5: 3.5 Kb cya gene fragment
Lane 6: 3.5 Kb cya gene fragment + 2 mM lAA and
1 ul of cell extract
Lane 7: Kb ladder
Lane 8: 2.4 Kb cva gene fragment + 2 mM lAA
Lane 9: 2.4 Kb cva gene fragment
Lane 10: 2.4 Kb cva gene fragment + 2 mH lAA +
1 ul of cell extract









In bacteria, cAMP and its receptor protein (CAP)
appear to govern a number of physiologically significant
processes. Not only does this complex participate
in the initial transcription steps of catabolite
sensitive operons, but it appears also to control directly
or indirectly the polarity of expression of polycistronic
operons by interfering with premature transcriptional
termination (Ullmann ^ , 1979). Our laboratory had
previously discovered that cAMP could also replace the
requirement for the relA gene in the synthesis of the ilv
biosynthetic enzyme, acetohydroxy acid synthase. The
intracellular level of cAMP in E^. coli varies depending
on carbon sources in culture media. For example, it has
been well known that cells growing on glucose contain
particularly low levels of cAMP. However, it is not clear
how glucose decreases the cAMP levels or more generally,
how the concentration of cAMP in the cells is regulated.
It is apparent that the regulation of the level and
activity of adenylate cyclase, the enzyme responsible for
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the synthesis of cAMP, plays an important role in the
control of cAMP concentration, but little is known about
the molecular mechanism(s) of the regulation of the cva
gene coding for adenylate cyclase.
To study directly the regulation of the adenylate
cyclase gene expression, our lab has cloned and
subcloned the 2.4 kb cva gene fragment onto pBR322 (via
lambda transducing phage) using various restriction
enzymes previously stated in the experimental procedure.
In this study, we have provided several lines of evidence
that indicated that the cloned gene fragment carries a
functional adenylate cyclase gene. First, bacterial
strain CA8306 (carrying a complete deletion in cva gene)
when transformed with the pCva4 recombinant plasmid was
able to grow on minimal maltose plates as well as produced
CAMP. This suggested that adenylate cyclase was produced
by the recombinant plasmid. Second, the DNA from these
plasmids consistently showed differences from that of the
parent pBR322 when electrophoresed on agarose gels. Third,
cva* transformants produced significant amounts of
adenylate cyclase and cAMP compared to cva* wild type
strains and cva' mutant strains isolated. Additionally,
high levels of )9-galactosidase were also produced in cva*
transformants. The fact that the cloned cva gene fragment
produced the 95,000 daltons adenylate cyclase (that
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paralleled the previously reported E. coli adenylate
cyclase), (Yang ^ al., 1980) suggested that this 2.4 kb
cloned cva fragment contains the entire adenylate cyclase
gene.
This study has also revealed the isolation of
cells deficient in the production of adenylate cyclase.
These cells cannot grow in minimal maltose and lactose
media. However, upon adding various concentrations of
CAMP to the growth media, a varying increase in the growth
rate of these mutants was observed (Figure 2). By adding
CAMP directly, the step catalyzed by adenylate cyclase was
bypassed, thereby, allowing mutants cells to grow on
catabolite carbon sources. The above properties of the
isolated adenylate cyclase regulatory mutants suggested
that CAMP is required for the utilization of a large
number of carbon sources. Simultaneously with the loss of
adenylate cyclase activity, the mutant was unable to
utilize normally a number of carbon sources. The fact
that CAMP restores the utilization of all these compounds
strongly suggested that the metabolic defects are all
secondary to the adenylate cyclase deficiency. Roy ^ al.
(1983) reported a study with plasmids containing in vivo
constructed fusions of cva to lacZ that caused a
stimulation of the rate of synthesis of )9-galactosidase
when 1 mM cAMP was added to growth media. Our present
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data are in agreement with this discovery; however, the
data do not rule out the possibility that intracellular
CAMP concentrations may also be regulated by the levels
of extracellular cAMP. It is also likely that the
intracellular levels of cAMP may be regulated by
phosphodiesterase or by RNA or protein degradation.
The fact that adenylate cyclase regulatory mutants CA8306,
when transformed with pCva4. produced significant amounts
of adenylate cyclase and cAMP also suggested that
adenylate cyclase gene expression plays some role in the
regulation of cAMP.
In bacteria, the ideal conditions that elicit high
levels of CAMP and adenylate cyclase are : (1) Amino acid
starvation; and (2) carbon shiftdown (i.e., the use of
poor carbon/energy sources). Under these conditions,
certain metabolites that are known to accumulate were
assessed relative to cya gene expression. Cell cultures
were employed in in vivo transcriptional/translational
systems in the presence and absence of certain
metabolites. In these cultures, the presence of adenylate
cyclase-catalyzed product, cAMP, resulted in a slight
inhibitory effect on the expression of adenylate cyclase
gene and cAMP production. These data suggested that the
proposed negative regulation of cAMP upon its own
synthesis could not fully account for the overall negative
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regulation of cAMP especially in the presence of glucose
minimal media. Other options such as degradation of cAMP
by CAMP phosphodiesterase and excretion of cAMP are also
possible. Indole and imidazole acetic acid produced a
small change on adenylate cyclase gene expression and cAMP
production. A slight decrease was noticed in the presence
of ppGpp. Indole acetic acid elicited a strong
stimulatory effect upon the expression of adenylate
cyclase and cAMP production. This in vivo experiment
paralleled the in vitro experiment previously performed
in our Laboratory (Baylor and Williams, unpublished) in
which the cloned cva gene fragment was employed in an in
vitro transcriptional/translational system in the presence
and absence of the above metabolite. From the plasmid-
encoded proteins harboring the cva gene fragment analyzed
by the "Maxicell” technique, it was found that indole
acetic acid (one of the metabolites that accumulates
during amino acid starvation) appeared to stimulate an
increased production of a protein band that corresponds
to the complete cva protein. To further understand the
possible role(s) of indole acetic acid, indole acetic acid
was utilized in a growth study of cells in minimal media.
Growth data indicated that indole acetic acid could not
serve as a carbon source, but rather as a modulator of cva
gene expression. An in vivo transcriptional/translational
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experiment in the presence and absence of rifampin further
indicated that the effect of indole acetic acid on cva
gene expression was at the transcriptional level.
In prokaryotes, it is known that cAMP plays a role
in the induction of certain catabolite-repressible operons
such as lactose, maltose, L-arabinose, and galactose
(Perlman ^ al., 1968; Pastan ^ , 1976). In all of
these systems, cAMP interacts with a protein molecule,
CAP, to function in gene regulation. Since indole acetic
acid was found to affect the expression of adenylate
cyclase and cAMP production, an experiment was conducted
to study whether indole acetic acid could circumvent the
necessity for cAMP in eliciting gene expression of the lac
operon of E. coli. Glucose elicited repression on the
expression of the lac operon in cells growing on minimal
maltose and lactose media supplemented with 1 mM lAA.
This repression was overcome when higher concentration of
lAA was present, as was the case with cAMP. On the basis
of these observations, we propose that critical levels of
certain small metabolic intermediates (i.e., indole acetic
acid) other than cAMP may play a role in directing the
regulation of gene expression. We regard this type of
control as ” metabolite gene regulation.”
From these studies in our laboratory, it is
becoming increasingly evident that in prokaryotic
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cells, naturally occurring metabolites other than cAMP
can function at the genetic level to control cell
activity, a concept we considered as "metabolite gene
regulation". Similar studies from other laboratories have
indicated that small metabolites such as indole and
imidazole derivatives could circumvent cAMP necessity in
the induction of the L-arabinose operon both in
prokaryotic and eukaryotic cells (Kline ^ , 1980;
Kline ^ , 1979; Daniel ^ al., 1981; Ullmann et al..
1983). Why indole acetic acid can circumvent cAMP
necessity in the induction of the lac operon is not
completely understood. With regard to possible
interactions of small metabolites with nucleic acids, it
was of interest that we examined whether indole acetic
acid could bind to the cva gene directly or via receptor
proteins. This interaction could provide some explanation
for the activation of the cva gene expression by indole
acetic acid. The results of the gel retardation studies
suggested that indole acetic acid could bind to the cva
gene fragment directly. Hendry ^ (1979) and Withan
(1977) demonstrated that histidine, trytophan, lAA, and
CAMP can intercalate into double-stranded sequences of RNA
and DNA and stress hydrogen bonding. It has also been
reported that polyhydroxylic compounds affect
transcription presumably by disrupting hydrogen bonding
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in the DNA molecule (Withan ^ al., 1977). This
disruption of hydrogen bonding was suggested to be a way
in which selective regions on the DNA could be enhanced
for recognition by RNA polymerase. Data from the gel
retardation experiments suggested that indole acetic acid
could induce a conformational change in the cva gene
fragment, and this change may be essential for the
activation of cva gene expression and cAMP production.
As previously stated, in bacteria, the ideal
conditions that elicit high levels of cAMP and adenylate
cyclase are amino acid starvation and carbon shiftdown
(i.e., use of poor carbon/energy sources). Under these
conditions, certain metabolites are also known to
accumulate. Persistent efforts to directly tie poor
carbon sources and amino acid starvation to the activation
of adenylate cyclase and cAMP production have proven
unsuccessful. On the basis of the data obtained from this
study, we are proposing that small metabolites, especially
indole acetic acid, can bind to the cva gene in such a way
as to activate the synthesis of adenylate cyclase gene
expression and cAMP production. Hence, this can account
for the accumulation of cAMP and adenylate cyclase under
amino acid starvation and poor carbon source conditions.
This proposed model is summarized in Figure 11. This
study have further demonstrated that indole acetic acid
Fig. 11. Proposed model for the regulation of adenylate
cyclase gene expression and cAMP production.
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can circumvent the necessity for cAMP in eliciting gene
expression in the lac operon of E. coli. and also can
overcome glucose-mediated catabolite repression.
CHAPTER VI
SUMMARY AND CONCLUSIONS
1. Adenylate cyclase gene regulatory mutants were
isolated and characterized;
2. A combination of restriction enzymes, EcoRl and BamHl.
was used to digest pBR322 and pCva4 plasmids.
Subsequent to digestion, a 0.4 kb fragment was
generated from pBR322 and pCva4 yielded a 2.4 kb gene
fragment;
3. There was a direct correlation between the
intracellular levels of cAMP, /3-galactosidase and
accumulation of adenylate cyclase. The cloned cva
gene fragment restored the above levels beyond normal
range within cva mutants;
4. The levels of adenylate cyclase, /3-galactosidase,
and CAMP were significantly elevated in cultures grown
in the presence of indole acetic acid;
5. Data obtained from the growth studies indicated that
indole acetic acid did not serve as a carbon source
but rather as an activator of cva gene expression;
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6. In vivo transcriptional/translational data indicated
that the modulation of cva gene expression by indole
acetic acid was at the transcriptional level;
7. Data from the binding and gel retardation experiments
suggested that indole acetic acid induced a
conformational change in the cva gene fragment and
this change appeared to be essential for the
activation of cva gene expression and cAMP production;
8. Data from the catabolite repression experiments
indicated that indole acetic acid can circumvent the
necessity for cAMP in eliciting gene expression in the
lac operon of E. coli and also can overcome glucose-
mediated catabolite repression;
9. Collectively, these data have demonstrated that small
metabolites, especially indole acetic acid participate
in the regulation of adenylate cyclase gene expression
and CAMP production. From this study, it is becoming
increasingly evident that naturally occurring
metabolites other than cAMP can function at the
genetic level to control cell activity, a concept we
considered as metabolite gene regulation". Thus,
indole acetic acid should be considered as another
cellular alarmone in enteric bacteria.
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